Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55

Journal of Neuroimmunology

Volumn 256, Issue 1-2, 2013, Pages 19-27

  Massilamany, Chandirasegaran ^a   Gangaplara, Arunakumar ^a   Kim, Heejeong ^a   Stanford, Charlotte ^a   Rathnaiah, Govardhan ^a   Steffen, David ^a   Lee, Jaekwon ^a   Reddy, Jay ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Autoimmunity; Experimental autoimmune encephalomyelitis; Oxidative stress; T cells

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17F; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME DEFICIENCY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; WILD TYPE;

AGE FACTORS; ANIMALS; ANTIGENS, CD4; BRAIN; CELL DEATH; CELL PROLIFERATION; CYTOKINES; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; FREUND'S ADJUVANT; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUTROPHIL INFILTRATION; PEPTIDE FRAGMENTS; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES; TIME FACTORS;

EID: 84875368656     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.12.004     Document Type: Article

References (58)

1. Barkats M., Bemelmans A.P., Geoffroy M.C., Robert J.J., Loquet I., Horellou P., Revah F., Mallet J. An adenovirus encoding CuZnSOD protects cultured striatal neurones against glutamate toxicity. NeuroReport 1996, 7:497-501.
2. Bettelli E., Oukka M., Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007, 8:345-350.
3. Carlson N.G., Rose J.W. Antioxidants in multiple sclerosis: do they have a role in therapy?. CNS Drugs 2006, 20:433-441.
4. Cemerski S., Cantagrel A., Van Meerwijk J.P., Romagnoli P. Reactive oxygen species differentially affect T cell receptor-signaling pathways. J. Biol. Chem. 2002, 277:19585-19593.
5. Cemerski S., van Meerwijk J.P., Romagnoli P. Oxidative-stress-induced T lymphocyte hyporesponsiveness is caused by structural modification rather than proteasomal degradation of crucial TCR signaling molecules. Eur. J. Immunol. 2003, 33:2178-2185.
6. Chan P.H., Kawase M., Murakami K., Chen S.F., Li Y., Calagui B., Reola L., Carlson E., Epstein C.J. Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. J. Neurosci. 1998, 18:8292-8299.
7. Devadas S., Zaritskaya L., Rhee S.G., Oberley L., Williams M.S. Discrete generation of superoxide and hydrogen peroxide by T cell receptor stimulation: selective regulation of mitogen-activated protein kinase activation and fas ligand expression. J. Exp. Med. 2002, 195:59-70.
8. Fischer L.R., Igoudjil A., Magrane J., Li Y., Hansen J.M., Manfredi G., Glass J.D. SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouse. Brain 2011, 134:196-209.
9. Fischer L.R., Li Y., Asress S.A., Jones D.P., Glass J.D. Absence of SOD1 leads to oxidative stress in peripheral nerve and causes a progressive distal motor axonopathy. Exp. Neurol. 2012, 233:163-171.
10. Freeman B.D., Reaume A.G., Swanson P.E., Epstein C.J., Carlson E.J., Buchman T.G., Karl I.E., Hotchkiss R.S. Role of CuZn superoxide dismutase in regulating lymphocyte apoptosis during sepsis. Crit. Care Med. 2000, 28:1701-1708.
11. Gangaplara A., Massilamany C., Brown D.M., Delhon G., Pattnaik A.K., Chapman N., Rose N., Steffen D., Reddy J. Coxsackievirus B3 infection leads to the generation of cardiac myosin heavy chain-alpha-reactive CD4 T cells in A/J mice. Clin. Immunol. 2012, 144:237-249.
12. Gelderman K.A., Hultqvist M., Holmberg J., Olofsson P., Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:12831-12836.
13. Gelderman K.A., Hultqvist M., Pizzolla A., Zhao M., Nandakumar K.S., Mattsson R., Holmdahl R. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J. Clin. Invest. 2007, 117:3020-3028.
14. Gilgun-Sherki Y., Melamed E., Offen D. The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J. Neurol. 2004, 251:261-268.
15. Griffiths H.R. ROS as signalling molecules in T cells-evidence for abnormal redox signalling in the autoimmune disease, rheumatoid arthritis. Redox Rep. 2005, 10:273-280.
16. Gunnett C.A., Heistad D.D., Berg D.J., Faraci F.M. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol. Heart Circ. Physiol. 2000, 279:H1555-H1562.
17. Guy J., Ellis E.A., Hope G.M., Rao N.A. Influence of antioxidant enzymes in reduction of optic disc edema in experimental optic neuritis. J. Free Radic. Biol. Med. 1986, 2:349-357.
18. Guy J., Ellis E.A., Hope G.M., Rao N.A. Antioxidant enzymes reduce loss of blood-brain barrier integrity in experimental optic neuritis. Arch. Ophthalmol. 1989, 107:1359-1363.
19. Hildeman D.A., Mitchell T., Teague T.K., Henson P., Day B.J., Kappler J., Marrack P.C. Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 1999, 10:735-744.
20. Holmberg J., Tuncel J., Yamada H., Lu S., Olofsson P., Holmdahl R. Pristane, a non-antigenic adjuvant, induces MHC class II-restricted, arthritogenic T cells in the rat. J. Immunol. 2006, 176:1172-1179.
21. Hopkins R.G., Failla M.L. Copper deficiency reduces interleukin-2 (IL-2) production and IL-2 mRNA in human T-lymphocytes. J. Nutr. 1997, 127:257-262.
22. Hultqvist M., Olofsson P., Holmberg J., Backstrom B.T., Tordsson J., Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:12646-12651.
23. Ishigami N., Isoda K., Adachi T., Niida T., Kujiraoka T., Hakuno D., Kondo H., Kusuhara M., Ohsuzu F. Deficiency of CuZn superoxide dismutase promotes inflammation and alters medial structure following vascular injury. J. Atheroscler. Thromb. 2011, 18:1009-1017.
24. Iuchi Y., Kibe N., Tsunoda S., Okada F., Bannai S., Sato H., Fujii J. Deficiency of the cystine-transporter gene, xCT, does not exacerbate the deleterious phenotypic consequences of SOD1 knockout in mice. Mol. Cell. Biochem. 2008, 319:125-132.
25. Iuchi Y., Okada F., Takamiya R., Kibe N., Tsunoda S., Nakajima O., Toyoda K., Nagae R., Suematsu M., Soga T., Uchida K., Fujii J. Rescue of anaemia and autoimmune responses in SOD1-deficient mice by transgenic expression of human SOD1 in erythrocytes. Biochem. J. 2009, 422:313-320.
26. Jager A., Dardalhon V., Sobel R.A., Bettelli E., Kuchroo V.K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 2009, 183:7169-7177.
27. Johnson F., Giulivi C. Superoxide dismutases and their impact upon human health. Mol. Aspects Med. 2005, 26:340-352.
28. Keithley E.M., Canto C., Zheng Q.Y., Wang X., Fischel-Ghodsian N., Johnson K.R. Cu/Zn superoxide dismutase and age-related hearing loss. Hear. Res. 2005, 209:76-85.
29. Kruisbeek A.M. In vitro assays for mouse lymphocyte function. Current Protocols in Immunology 2006, vol. 1:1-36. John Wiley & Sons, Inc.
30. Kunst C.B., Messer L., Gordon J., Haines J., Patterson D. Genetic mapping of a mouse modifier gene that can prevent ALS onset. Genomics 2000, 70:181-189.
31. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005, 201:233-240.
32. Li S., Vana A.C., Ribeiro R., Zhang Y. Distinct role of nitric oxide and peroxynitrite in mediating oligodendrocyte toxicity in culture and in experimental autoimmune encephalomyelitis. Neuroscience 2011, 184:107-119.
33. Ma Q., Battelli L., Hubbs A.F. Multiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2. Am. J. Pathol. 2006, 168:1960-1974.
34. Massilamany C., Steffen D., Reddy J. An epitope from Acanthamoeba castellanii that cross-react with proteolipid protein 139-151-reactive T cells induces autoimmune encephalomyelitis in SJL mice. J. Neuroimmunol. 2010, 219:17-24.
35. Massilamany C., Asojo O.A., Gangaplara A., Steffen D., Reddy J. Identification of a second mimicry epitope from Acanthamoeba castellanii that induces CNS autoimmunity by generating cross-reactive T cells for MBP 89-101 in SJL mice. Int. Immunol. 2011, 23:729-739.
36. Massilamany C., Thulasingam S., Steffen D., Reddy J. Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139-151 in SJL mice. J. Neuroimmunol. 2011, 230:95-104.
37. Massilamany C., Upadhyaya B., Gangaplara A., Kuszynski C., Reddy J. Detection of autoreactive CD4 T cells using major histocompatibility complex class II dextramers. BMC Immunol. 2011, 12:40.
38. Matzuk M.M., Dionne L., Guo Q., Kumar T.R., Lebovitz R.M. Ovarian function in superoxide dismutase 1 and 2 knockout mice. Endocrinology 1998, 139:4008-4011.
39. Meissner F., Molawi K., Zychlinsky A. Superoxide dismutase 1 regulates caspase-1 and endotoxic shock. Nat. Immunol. 2008, 9:866-872.
40. Mendel I., Kerlero de Rosbo N., Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur. J. Immunol. 1995, 25:1951-1959.
41. Mohammedi K., Maimaitiming S., Emery N., Bellili-Munoz N., Roussel R., Fumeron F., Hadjadj S., Marre M., Velho G. Allelic variations in superoxide dismutase-1 (SOD1) gene are associated with increased risk of diabetic nephropathy in type 1 diabetic subjects. Mol. Genet. Metab. 2011, 104:654-660.
42. Murakami K., Murata N., Noda Y., Tahara S., Kaneko T., Kinoshita N., Hatsuta H., Murayama S., Barnham K.J., Irie K., Shirasawa T., Shimizu T. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease. J. Biol. Chem. 2011, 286:44557-44568.
43. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic. Biol. Med. 2001, 31:1287-1312.
44. Pahlavani M.A., Mele J.F., Richardson A. Effect of overexpression of human Cu/Zn-SOD on activation-induced lymphocyte proliferation and apoptosis. Free Radic. Biol. Med. 2001, 30:1319-1327.
45. Qi X., Lewin A.S., Sun L., Hauswirth W.W., Guy J. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis. Invest. Ophthalmol. Vis. Sci. 2007, 48:681-691.
46. Reddy J., Chastagner P., Fiette L., Liu X., Theze J. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation. Int. Immunol. 2001, 13:135-147.
47. Sareila O., Kelkka T., Pizzolla A., Hultqvist M., Holmdahl R. NOX2 complex-derived ROS as immune regulators. Antioxid. Redox Signal. 2011, 15:2197-2208.
48. Schreibelt G., van Horssen J., van Rossum S., Dijkstra C.D., Drukarch B., de Vries H.E. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res. Rev. 2007, 56:322-330.
49. Siomek A., Brzoska K., Sochanowicz B., Gackowski D., Rozalski R., Foksinski M., Zarakowska E., Szpila A., Guz J., Bartlomiejczyk T., Kalinowski B., Kruszewski M., Olinski R. Cu, Zn-superoxide dismutase deficiency in mice leads to organ-specific increase in oxidatively damaged DNA and NF-kappaB1 protein activity. Acta Biochim. Pol. 2010, 57:577-583.
50. Sobel R.A., Tuohy V.K., Lu Z.J., Laursen R.A., Lees M.B. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropathol. Exp. Neurol. 1990, 49:468-479.
51. Stromnes I.M., Cerretti L.M., Liggitt D., Harris R.A., Goverman J.M. Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 2008, 14:337-342.
52. Sun D., Whitaker J.N., Huang Z., Liu D., Coleclough C., Wekerle H., Raine C.S. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 2001, 166:7579-7587.
53. Sun D., Zhang Y., Wei B., Peiper S.C., Shao H., Kaplan H.J. Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules. Int. Immunol. 2003, 15:261-268.
54. Sun Q.A., Su D., Novoselov S.V., Carlson B.A., Hatfield D.L., Gladyshev V.N. Reaction mechanism and regulation of mammalian thioredoxin/glutathione reductase. Biochemistry 2005, 44:14528-14537.
55. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
56. van Meeteren M.E., Hendriks J.J., Dijkstra C.D., van Tol E.A. Dietary compounds prevent oxidative damage and nitric oxide production by cells involved in demyelinating disease. Biochem. Pharmacol. 2004, 67:967-975.
57. Yamada M., Shichi H., Yuasa T., Tanouchi Y., Mimura Y. Superoxide in ocular inflammation: human and experimental uveitis. J. Free Radic. Biol. Med. 1986, 2:111-117.
58. Zambricki E., Shigeoka A., Kishimoto H., Sprent J., Burakoff S., Carpenter C., Milford E., McKay D. Signaling T-cell survival and death by IL-2 and IL-15. Am. J. Transplant. 2005, 5:2623-2631.